The aim of this study was to investigate the alteration of the gait pattern in 25 children with Duchenne muscular dystrophy, using body-worn inertial sensors during a long walking distance. Normalized spatiotemporal gait parameters and their variability were extracted from the angular velocity of the shanks; the smoothness of the trunk movement was assessed based on the spectral entropy of the acceleration norm. As compared to healthy children, patients with Duchenne muscular dystrophy showed significantly lower stride velocity and a less smooth trunk movement. When the group of patients was divided into mild and moderate based on the Motor Function Measure, the authors noticed significantly higher values both for cadence and stride velocity, as well as improved trunk smoothness in the mild versus moderate group. The potential of such parameters to distinguish between different disease states opens new perspectives for the objective assessment of efficacy of the new therapies associated with Duchenne muscular dystrophy.
SutherlandDHOlshenRCooperL. The pathomechanics of gait in Duchenne muscular dystrophy. Dev Med Child Neurol. 1981;23(1):3–22.
2.
BushbyKFinkelRBirnkrantDJ. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2009;9(1):77–93.
3.
ScottOMHydeSAGoddardCDubowitzV.Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy. Muscle Nerve. 1982;5(4):291–301.
4.
BérardCPayanCHodgkinsonIFermanianJ.MFM Collaborative Study Group. A motor function measure for neuromuscular diseases: construction and validation study. Neuromuscul Disord. 2005;15(7):463–470.
5.
IannacconeST.Outcome measures for pediatric spinal muscular atrophy. Arch Neurol. 2002;59(9):1445–1450.
6.
MercuriEMessinaSPaneMBertiniE.Current methodological issues in the study of children with inherited neuromuscular disorders. Dev Med Child Neurol. 2008;50(6):417–421.
7.
HsuJDFurumasuJ.Gait and posture changes in the Duchenne muscular dystrophy child. Clin Orthop Relat Res. 1993;288:122–125.
8.
ArmandSMercierMWatelainEPatteKPelissierJRivierF.A comparison of gait in spinal muscular atrophy, type II and Duchenne muscular dystrophy. Gait Posture. 2005;21(4):369–378.
9.
Sienko ThomasSBuckonCENicoriciABagleyAMcDonaldCMSussmanMD.Classification of the gait patterns of boys with Duchenne muscular dystrophy and their relationship to function. J Child Neurol. 2010;25(9):1103–1109.
10.
BrandesMZijlstraWHeikensSvan LummelRRosenbaumD.Accelerometry based assessment of gait parameters in children. Gait Posture. 2006;24(4):482–486.
11.
SalarianARussmannHVingerhoetsFJ. Gait assessment in Parkinson’s disease: toward an ambulatory system for long-term monitoring. IEEE Trans Biomed Eng. 2004;51(8):1434–1443.
12.
RochatSBülaCJMartinEWhat is the relationship between fear of falling and gait in well-functioning older persons aged 65 to 70 years?Arch Phys Med Rehab. 2010;91(6):879–884.
13.
AlletLArmandSde BieRA. Gait alterations of diabetic patients while walking on different surfaces. Gait Posture. 2009;29(3):488–493.
14.
DejnabadiHJollesBMAminianK.A new approach for quantitative analysis of inter-joint coordination during gait. IEEE Trans Biomed Eng. 2008;55(2):755–764.
15.
JeannetP-YAminianKBloetzerCNajafiBParaschiv-IonescuA.Continuous monitoring and quantification of multiple parameters of daily physical activity in ambulatory Duchenne muscular dystrophy patients. Eur J Paediatr Neurol. 2011;15:40–47.
16.
SchröterJGüthVOverbeckMRosenbaumDWinkelmannW.A hip unloading gait as a new conservative therapy for hip pain in the adult. Gait Posture. 1999;9(3):151–157.
17.
KamruzzamanJBeggRK.Support vector machines and other pattern recognition approaches to the diagnosis of cerebral palsy gait. IEEE Trans Biomed Eng. 2006;53(12):2479–2490.
18.
McDonaldCMHenricsonEKHanJJ. The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy. Muscle Nerve. 2009;41(4):500–510.
19.
SalarianARussmannHVingerhoetsFJGBurkhardPRAminianK.Ambulatory monitoring of physical activities in patients with Parkinson’s disease. IEEE Trans Biomed Eng. 2007;54(12):2296–2299.
20.
SalarianA.Ambulatory Monitoring of Motor Functions in Patients With Parkinson’s Disease Using Kinematic Sensors. Thèse EPFL, no 3475. Lausanne, Switzerland: École polytechnique fédérale de Lausanne; 2006.
21.
AminianKNajafiBBülaCLeyvrazPFRobertP.Spatio-temporal parameters of gait measured by an ambulatory system using miniature gyroscopes. J Biomech. 2002;35(5):689–699.
22.
HofAL.Scaling gait data to body size. Gait Posture. 1996;4(3):222–223.
23.
WinterDA.Biomechanics and Motor Control of Human Movement. 4th ed. New York: John Wiley; 2009.
24.
HausdorffJMCudkowiczMEFirtionRWeiJYGoldbergerAL.Gait variability and basal ganglia disorders: stride-to-stride variations of gait cycle timing in Parkinson’s disease and Huntington’s disease. Mov Disord. 1998;13(3):428–437.
25.
MakiBE.Gait changes in older adults: predictors of falls or indicators of fear?J Am Geriatr Soc. 1997;45(3):313–320.
26.
HausdorffJMRiosDAEdelbergHK.Gait variability and fall risk in community-living older adults: a 1-year prospective study. Arch Phys Med Rehabil. 2001;82(8):1050–1056.
27.
HahnGJShapiroSS.Statistical Models in Engineering. Hoboken, NJ: John Wiley; 1994
28.
KojimaMObuchiSMizunoKHenmiOIkedaN.Power spectrum entropy of acceleration time-series during movement as an indicator of smoothness of movement. J Physiol Anthropol. 2008;27(4):193–200.
29.
PapadakisNCChristakisDGTzagarakisGN. Gait variability measurements in lumbar spinal stenosis patients: part A. Comparison with healthy subjects. Physiol Meas. 2009;30(11):1171–1186.
30.
InouyeTShinosakiKSakamotoH. Quantification of EEG irregularity by use of the entropy of the power spectrum. Electroencephalogr Clin Neurophysiol. 1991;79(3):204–210.
31.
SleighJWSteyn-RossDASteyn-RossMLGrantCLudbrookG.Cortical entropy changes with general anaesthesia: theory and experiment. Physiol Meas. 2004;25(4):921–934.
32.
ThalheimerWCookS.How to calculate effect sizes from published research articles: a simplified methodology. 2010. Retrieved February 30, 2011 fromhttp://work-learning.com/effect_sizes.htm
33.
HedgesLOlkinI.Statistical Methods for Meta-Analysis. New York: Academic Press; 1985.
34.
CohenJ. In: Statistical Power Analysis for the Behavioral Science. 2nd ed.
Hillsdale, NJ: Lawrence Erlbaum; 1998.
35.
FriedmanJH.Regularized discriminant analysis. J Am Stat Assoc. 1989;84(405):165–175.
36.
FawcettT.An introduction to ROC analysis. Pattern Recognition Lett. 2006;27(8):861–874.
37.
D’AngeloMGBertiMPiccininiL. Gait pattern in Duchenne muscular dystrophy. Gait Posture. 2009;29(1):36–41.
38.
GaudreaultNGravelDNadeauSHoudeSGagnonD.Gait patterns comparison of children with Duchenne muscular dystrophy to those of control subjects considering the effect of gait velocity. Gait Posture. 2010;32(3):342–347.
39.
HausdorffJMZemanyLPengC-KGoldbergerAL.Maturation of gait dynamics: stride-to-stride variability and its temporal organization in children. J Appl Physiol. 1999;86(3): 1040–1047.
40.
Katz-LeurerMRotemHLewitusHKerenOMeyerS.Relationship between balance abilities and gait characteristics in children with post-traumatic brain injury. Brain Inj. 2008;22(2):153–159.
41.
PatteKPelissierJBernaimC. Gait analysis in Duchenne muscular dystrophy. Annales de Readaptation et de Medecine Physique. 2000;43:57–68.
42.
DesguerreIChristovCMayerM.. Clinical heterogeneity of Duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up. PLoS One. 2009;4(2):e4347.
